Governance & Accountability Institute announces its support of the Global Sourcing Council's "17 Weeks / 17 SDGs Initiative," developed by GSC in support of the Sustainable Development Goals (SDGs) that were adopted by all 193 countries at the United Nations Sustainable Development Summit in September 2015.
Last week, more than 2,000 global leaders convened in Davos, Switzerland at the World Economic Forum (WEF) Annual Meeting to answer one question: how can we master the Fourth Industrial Revolution?
Last year, our Research and Development team was called on by the U.S. Centers for Disease Control and Prevention (CDC) to develop a more effective screen for hepatitis C, a chronic blood-borne infection that was going undetected in large numbers of “baby boomers.” Swift action led to a one-time test now covered by Medicare and Medicaid that will help protect 3.2 million Americans against outcomes like liver damage, cirrhosis, liver cancer and even death.
To mark National Cancer Prevention Month, the Bristol-Myers Squibb Foundation today announced eight grants totaling nearly $11.5 million that will help make lung and skin cancer screening programs, care and patient support more accessible to underserved populations.
With the upcoming World Cancer Day on Feb. 4, Cox Enterprises announced a $200,000 donation to be shared equally by Susan G. Komen Greater Atlanta and the Movember Foundation.
The five winners of the first ever Global Change Award have been selected by the expert jury. The ideas range from creating new textile out of citrus juice by-products and an online marketplace for recycling of textile leftovers to using microbes to recycle waste polyester. Now, the global public is asked to allocate the €1 million grant between the winners in an online vote starting today at globalchangeaward.com.
“The End of Sitting” is an experimental office space that uses its unique design to encourage workers to stand, lean or lie against its many three-dimensional shapes.
On World Leprosy Day 2016, the Novartis Foundation calls for a greater global commitment to the fight against leprosy to support efforts towards zero transmission of the disease and to reduce stigma. The Novartis Foundation continues to work with partners around the world on early detection and treatment of leprosy, proactive surveillance, the development of diagnostic tools, and contact tracing with preventative treatment.